CA 19-9 Tumour Marker Test

The CA 19-9 tumour marker test is a blood test used to measure the level of CA 19-9, a protein often found in higher amounts in people with certain types of cancer, especially pancreatic cancer. This test helps doctors monitor the presence and progression of cancer and the effectiveness of treatment.

What is a CA 19-9 Tumour Marker Test?

CA 19-9, a mucin-type glycoprotein often called a carbohydrate antigen, is produced by both cancerous and non-cancerous cells, but its levels are more elevated in certain cancers. It is most commonly associated with pancreatic cancer but can also be elevated in other types of cancer, such as colorectal and bile duct cancers, as well as in non-cancerous conditions like pancreatitis and liver disease. The CA 19-9 tumour marker test is mainly used to help diagnose and manage cancer treatment rather than as a routine screening tool for cancer.

Why is the Test Important?

The CA 19-9 tumour marker test plays a critical role in managing certain cancers for several reasons:

Supporting Diagnosis

The CA 19-9 test can support other diagnostic procedures. If CA 19-9 levels are high, doctors may conduct further tests to investigate the possibility of cancer.

Detecting Cancer Recurrence

After successful treatment, the CA 19-9 test can be used to monitor for cancer recurrence. Regular testing can detect rising CA 19-9 levels early, allowing doctors to take action quickly if the cancer returns.

Providing Prognostic Information

The level of CA 19-9 in the blood can also provide information about the prognosis of the condition. Higher levels of CA 19-9 at diagnosis or persistently elevated levels despite treatment are often associated with a more advanced stage of cancer and poorer prognosis.

Monitoring Cancer Treatment Effectiveness

For patients undergoing cancer treatment, such as chemotherapy or surgery, the CA 19-9 tumour marker test helps doctors see how well the treatment works. If CA 19-9 levels decrease during treatment, it often indicates that the cancer is responding to therapy.

Who Should Get Tested?

The CA 19-9 tumour marker test is particularly useful for certain groups of people:

  • Diagnosed Cancer Patients: The CA 19-9 test is routinely used to monitor treatment effectiveness for patients diagnosed with pancreatic or biliary cancers. Regular testing can help track the cancer’s response to therapies like surgery, chemotherapy, or radiation.
  • High-Risk Patients: Those with a family history of pancreatic cancer or genetic predispositions may undergo CA 19-9 testing as part of their surveillance program. This helps in early detection and timely intervention, potentially improving outcomes.
  • Symptomatic Patients: Those showing symptoms such as jaundice, unexplained weight loss, or abdominal pain may be tested for CA 19-9 to help support a diagnosis of pancreatic or other related cancers.

How the CA 19-9 Tumour Marker Test Works

The CA 19-9 tumour marker test is a simple blood test that measures the level of the CA 19-9 protein in the bloodstream. Here’s how the process works:

Blood Sample Collection

A doctor will draw a small blood sample, typically from a vein in your arm. The procedure is quick and involves minimal discomfort, similar to a routine blood draw.

Laboratory Analysis

The blood sample is sent to a laboratory and analysed using specific techniques to determine the amount of CA 19-9 present. The results are usually available within a few days.

Follow-Up Testing

The CA 19-9 test may be repeated regularly for those undergoing cancer treatment to monitor changes in the CA 19-9 levels. A decrease in levels usually indicates a positive response to treatment, while an increase may suggest the need for further investigation or a change in treatment strategy.

Preparing for the Test

Preparing for a CA 19-9 tumour marker test is straightforward. Here are some key steps and considerations:

Consult with Your Doctor

Discuss with your doctor any medications you are currently taking, including prescription, over-the-counter, supplements, and herbal products. Certain substances can interfere with test results, and your doctor may temporarily advise you to discontinue specific medications before the test.

Fasting Requirements

Sometimes, your doctor may recommend fasting for a specific period before the test. Fasting usually means not eating or drinking anything except water for several hours, typically 8-12 hours before the blood draw. Be sure to follow these instructions exactly if they apply to you.

Wear Appropriate Clothing

Wear comfortable clothing with sleeves that can be easily rolled up to allow easy access to your arm. This will facilitate a quicker and more efficient blood draw.

Dietary Considerations

If your doctor has not provided specific fasting instructions, it is still a good idea to avoid heavy or fatty meals before the test. Eating a balanced meal several hours before the test can help maintain stable blood sugar levels and prevent light-headedness.

What to Expect During the Test

The CA 19-9 tumour marker test is a straightforward procedure. Here’s what you can expect:

Upon arriving at the clinic or laboratory, you will check-in and may need to complete some paperwork. This usually includes providing your medical history and any current medications.

A doctor will escort you to a comfortable area where the blood draw will occur. They will ask you to sit or lie down and explain the procedure if required.

  • Sterilisation: The doctor will clean the area on your arm where the blood will be drawn using an antiseptic wipe to prevent infection.
  • Tourniquet Application: A tourniquet (a tight band) will be placed around your upper arm to make your veins more visible and easier to access.
  • Needle Insertion: A sterile needle will be inserted into a vein, usually in your arm. You may feel a slight pinch or sting during this process.
  • Blood Collection: Blood will be drawn into one or more tubes. This process typically takes a few minutes.
  • Needle Removal: Once enough blood has been collected, the needle will be removed, and a piece of gauze or cotton ball will be placed over the puncture site to stop any bleeding.
  • Bandaging: The site will then be bandaged to protect it and prevent any further bleeding.

After the blood draw, there are a few steps you should take to ensure your well-being and proper care of the puncture site:

  • Rest: You may be asked to sit for a few minutes to ensure you feel well after the blood draw.
  • Hydration and Food: Drink water and have a light snack if you feel light-headed or dizzy.
  • Care of the Puncture Site: Keep the bandage on for a few hours and avoid strenuous activities with the arm used for the blood draw to prevent bruising.

The blood sample will be sent to a laboratory for analysis. Your doctor will receive the results within a few days and discuss them with you during a follow-up appointment. They will explain the CA 19-9 levels for your overall health and any ongoing treatments.

Understanding Your Results

To interpret the CA 19-9 tumour marker test results, it is important to understand what CA 19-9 levels mean for your health. General guidelines are below, but your doctor will explain your results:

Normal Range

The normal range for CA 19-9 is typically between 0 and 37 units per millilitre (U/mL). Levels within this range are generally considered normal and do not indicate the presence of cancer.

Elevated Levels

Higher than normal levels of CA 19-9 can indicate several conditions:

  • Pancreatic Cancer: Elevated CA 19-9 levels are often associated with pancreatic cancer. The higher the level, the more progressive the cancer may be.
  • Other Cancers: Elevated levels may also be seen in cancers of the bile ducts, colon, stomach, and liver.
  • Benign Conditions: Non-cancerous conditions such as pancreatitis, liver disease, gallstones, and cystic fibrosis can also cause elevated CA 19-9 levels.

Trends in CA 19-9 Levels

For people who are getting treatment for cancer, the increase in CA 19-9 levels over time is often more important than a single measurement.

  • Decreasing Levels: A decrease in CA 19-9 levels typically indicates that the treatment is effective and the tumour burden is decreasing.
  • Increasing Levels: An increase in CA 19-9 levels may suggest that the cancer is not responding to treatment, is progressing, or has recurred. Further diagnostic tests and clinical evaluations are usually required to determine the cause.

Follow-Up and Next Steps

After receiving your CA 19-9 test results, the next steps will depend on your situation and the test findings. Here’s what to expect:

If you have been diagnosed with cancer and are undergoing treatment, your doctor may schedule regular CA 19-9 tests to monitor your progress. These tests help track how well your treatment works and detect any changes in your condition. The frequency of these tests will depend on your specific treatment plan and overall health status.

If your CA 19-9 levels are elevated, your doctor may recommend further diagnostic tests to gain more information about your condition. This could include imaging studies such as CT scans, MRIs, or PET scans to look for tumours or other abnormalities. In some cases, a biopsy may be needed to confirm a diagnosis.

Based on your CA 19-9 levels and other diagnostic findings, your doctor may suggest changes to your treatment plan. This could involve modifying the dosage of chemotherapy, trying a different type of treatment, or considering surgical options if appropriate.

If your treatment is causing side effects, your doctor will work with you to manage these symptoms. This might include prescribing medications to alleviate nausea, pain, or other common side effects of cancer treatment.

Even after successful treatment, long-term follow-up is important to monitor for any signs of cancer recurrence. Your doctor will establish a follow-up schedule that includes periodic CA 19-9 tests and other evaluations to monitor your health and detect any issues early.

Limitations of the CA 19-9 Test

Although the CA 19-9 test provides valuable information, it has limitations:

Variable Sensitivity and Specificity

CA 19-9 test sensitivity and specificity vary. Test sensitivity is its capacity to identify people with the condition, while specificity is its ability to identify those without. CA 19-9’s sensitivity and specificity are too low for cancer screening or diagnosis.

Not to Be Used Alone as A Screening Tool

The CA 19-9 test cannot be used alone to diagnose cancer. Elevated CA 19-9 levels can occur in various conditions, both cancerous and non-cancerous. It must be combined with other diagnostic tests and clinical evaluations to diagnose cancer accurately.

Monitoring Challenges

The CA 19-9 test helps track treatment response and detect recurrence, although its levels vary. Consistent trends in CA 19-9 levels are more informative than a single test result.

False Positives/Negatives

Elevated CA 19-9 levels do not always indicate cancer and normal levels do not always rule it out. Other diagnostic tools and clinical evaluations are necessary to make an accurate diagnosis.

Limited Use in Early Detection

The CA 19-9 test is ineffective for early cancer detection. It is typically used for patients who have already been diagnosed with cancer or are at high risk. Its role in routine cancer screening is limited due to its lack of specificity and sensitivity in early-stage cancer.

Our clinics are under the following

insurance panels

For Singaporeans, Singapore Permanent Residents and Foreigners.
Please speak to our friendly clinic staff about using your insurance plans.

Reach Out To Us

We are committed to providing a one-stop experience, where you’ll receive a meticulous consultation and high-quality service in a comfortable environment.

Get Started

Book An Appointment





    image

    • Book An Appointment

    • Media Enquiry

    • Partnership Opportunity



    image

    For faster response, Call Us

    (65) 6733 3383



    CA 19-9 Tumour Marker Test

    Frequently Asked
    Questions

    Are there any risks associated with the CA 19-9 test?

    The CA 19-9 test involves a standard blood draw, which carries minimal risks, such as slight bruising or discomfort at the puncture site. Serious complications are very rare.

    How often should the CA 19-9 test be repeated?

    The frequency of the CA 19-9 test depends on personal circumstances, including the type of cancer, the stage of the disease, and the treatment plan. Your doctor will determine the appropriate follow-up testing schedule.

    Can the CA 19-9 test be used for routine cancer screening?

    No, the CA 19-9 test is not recommended for routine cancer screening in the general population due to its limited specificity and the potential for false positives and negatives.

    What should I do if my CA 19-9 levels are elevated?

    If your CA 19-9 levels are elevated, follow your doctor’s recommendations for additional tests and evaluations. Elevated levels do not necessarily mean you have cancer, but they do warrant further examination.